MARKET

DHTRF

DHTRF

DRI HEALTHCARE TRUST
OTCPK
13.91
NaN%
Closed 09:30 08/14 EDT
OPEN
--
PREV CLOSE
13.91
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
13.91
52 WEEK LOW
10.62
MARKET CAP
764.68M
P/E (TTM)
-15.5003
1D
5D
1M
3M
1Y
5Y
1D
DRI Healthcare Posts Record Q1 Income and Bolsters Balance Sheet With New Funding
TipRanks · 17h ago
DRI Healthcare (DHT.UN) Receives a Buy from RBC Capital
TipRanks · 3d ago
DRI Healthcare (DHT.UN) Gets a Buy from CIBC
TipRanks · 3d ago
DRI Healthcare Realizes US$178 Million from EKTERLY Royalty Exit
TipRanks · 3d ago
DRI Healthcare Trust declares $0.11 dividend
Seeking Alpha · 5d ago
DRI Healthcare Posts Record Q2 Results, Executes Ekterly Put and Adds Biopharma Experts to Board
TipRanks · 08/07 21:40
CIBC Remains a Buy on DRI Healthcare (DHT.UN)
TipRanks · 07/30 19:15
CIBC Keeps Their Buy Rating on DRI Healthcare (DHT.UN)
TipRanks · 07/14 01:47
More
About DHTRF
DRI Healthcare Trust is a global pharmaceutical royalty monetization company. The Company's portfolio consists of 29 royalty streams on 23 products that treat conditions in a number of therapeutic areas, including oncology, neurology, ophthalmology, endocrinology, hematology, dermatology, as well as lysosomal storage disorders (LSD) and immunology. Its Royalty Assets include Ekterly, Eylea I, Eylea II, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Spinraza, Vonjo I, Vonjo II, Xolair, Zejula, Zytiga, and others. The Ekterly is an oral on-demand therapy for treating attacks associated with Hereditary Angioedema (HAE). The Eylea I is a vascular endothelial growth factor inhibitor initially indicated for the treatment of neovascular wet age-related macular degeneration. Natpara is indicated as an adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism.

Webull offers DRI Healthcare Trust stock information, including OTCPK: DHTRF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DHTRF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DHTRF stock methods without spending real money on the virtual paper trading platform.